When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

22.3.2023

Widespread Disease Osteoarthritis: Interview with University Prof. Dr. Stefan Nehrer

Univ.-Prof. Dr. Stefan Nehrer, head of the Center for Regenerative Medicine at the University for Continuing Education Krems, gives an interview about the widespread disease osteoarthritis while sitting in a laboratory.

Everyone is talking about this widespread disease. According to a new study by University Prof. Dr. Stefan Nehrer, specialist in orthopedics and orthopedic surgery, the joint administration of cortisone with hyaluronic acid attenuates the cartilage-damaging effects.

Cingal is a highly effective single shot therapy for the treatment of osteoarthritis. It combines the immediate inflammatory and pain-relieving effect of cortisone tramcinolone hexacetonide with the long-lasting effectiveness of cross-linked hyaluronic acid with the highest active ingredient content - for proven rapid and long-lasting pain relief.

Would you like to find out more about Cingal? You can also download all information on our product page!

To the Cingal product page

Für weitere Informationen kontaktieren Sie bitte:

More posts

Product Presentation

Stem cell therapy for degenerative joint diseases

In an Ö24 interview, Prof. Dr. Zimpfer provides insights into stem cell therapy and new approaches .
Sponsoring

Lotteries Sporthilfe Gala 2024: A Celebration of Austrian Sports Talent

Outstanding local athletes were honored at the 28th LOTTERIES Sports Aid Gala in the Wiener Stadthalle.
Sponsoring

Haemo Pharma & WINBACK: Live at the Erste Bank Open 2024!

From 19-27. 10, the best tennis players will fight at the Erste Bank Open and we are proud to be an official sponsor.

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.